Evidence map›Paper›PMID 34721498›Full record

ArticleDementia and geriatric cognitive disorders extra

Prevalence of Dementia and Associated Factors among Older Adults in Latin America during the COVID-19 Pandemic.

Marcio Soto-Añari, Loida Camargo, Miguel Ramos-Henderson, Claudia Rivera-Fernández, Lucia Denegri-Solís, Ursula Calle, Nicanor Mori, Ninoska Ocampo-Barbá, Fernanda López, Maria Porto and 6 more

Abstract read
In one paragraph

Article in Dementia and geriatric cognitive disorders extra. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. [Cognitive function groups in older people and risk factors].Revista medica del Instituto Mexicano del Seguro Social · 2024
    Article
  6. Review
  7. Observational
  8. Article
  9. Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19.European review for medical and pharmacological sciences · 2022
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Marcio Soto-AñariLaboratorio de Neurociencia, Departamento de Psicología, Universidad Católica San Pablo, Arequipa, Peru.
Loida CamargoEscuela de Medicina, Universidad del Sinú, Cartagena de Indias, Colombia.
Miguel Ramos-HendersonCentro de Investigación e Innovación en Gerontología Aplicada (CIGAP), Facultad de Salud, Universidad Santo Tomás, Santiago, Chile.
Claudia Rivera-FernándezUniversidad Nacional de San Agustín de Arequipa, Arequipa, Peru.
Lucia Denegri-SolísUniversidad Nacional de San Agustín de Arequipa, Arequipa, Peru.
Ursula CalleClínica Delgado-Auna, Lima, Peru.
Nicanor MoriClínica Delgado-Auna, Lima, Peru.
Ninoska Ocampo-BarbáInstituto de Neurociencias Comportamentales (INCC), Universidad Autónoma Gabriel René Moreno (UAGRM), Santa Cruz de la Sierra, Bolivia.
Fernanda LópezHospital Nacional Dr. Alejandro Posadas, Buenos Aires, Argentina.
Maria PortoUniversidad de La Costa, Barranquilla, Colombia.
Nicole Caldichoury-ObandoDepartamento de Ciencias Sociales, Universidad de Los Lagos, Osorno, Chile.
Carol SaldíasFacultad de Ciencias de la Salud, Universidad San Sebastián, Valdivia, Chile.
Pascual GargiuloLaboratorio de Neurociencias y Psicología Experimental, CONICET, Facultad de Ciencias Médicas, Universidad Nacional de Cuyo, Mendoza, Argentina.
Cesar CastellanosInstituto Dominicano para el estudio de la Salud Integral y la Psicología Aplicada (IDESIP), Santo Domingo, Dominican Republic.
Salomon Shelach-BellidoLaboratorio de Neurociencia, Departamento de Psicología, Universidad Católica San Pablo, Arequipa, Peru.
Norman LópezUniversidad de La Costa, Barranquilla, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic has had a great impact on cognitive health in Latin American older adults, increasing the risk of cognitive impairment and dementia. Our objective was to analyze the prevalence of dementia and the associated factors in Latin American older adults during SARS-CoV-2 pandemic.

methodsA multicentric first phase cross-sectional observational study was conducted during the SARS-CoV-2 pandemic. Five thousand two hundred and forty-five Latin American adults over 60 years of age were studied in 10 countries: Argentina, Bolivia, Chile, Colombia, Ecuador, Guatemala, Mexico, Peru, the Dominican Republic, and Venezuela. We used the telephone version of Montreal Cognitive Assessment, the "Alzheimer Disease 8" scale for functional and cognitive changes, and the abbreviated version of the Yesavage depression scale. We also asked for sociodemographic and lockdown data. All the evaluation was made by telephone. Cross-tabulations and χ

resultsWe observed that the prevalence of dementia in Latin America is 15.6%, varying depending on the country (Argentine = 7.83 and Bolivia = 28.5%). The variables most associated with dementia were race and age. It does not seem to be associated with the pandemic but with social and socio-health factors.

conclusionThe prevalence of dementia shows a significant increase in Latin America, attributable to a constellation of ethnic, demographic, and socioeconomic factors.

Indexed as

AgingCOVID-19DementiaEthnicityPrevalence

Identifiers

PMID34721498
PMCPMC8543347

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.